HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy.

Abstract
Genes encoding Ca(2+) regulatory proteins responsible for Ca(2+) homeostasis have been suggested as possible candidates for FHC. Mutations in sarcomere genes account for approximately 50% of all FHC cases indicating other genes, including those involved in Ca(2+) handling, may account for the remainder. The aim of this study was to identify causative mutations in genes involved in Ca(2+) regulation in patients with familial hypertrophic cardiomyopathy (FHC). An Australian cohort of 252 unrelated familial hypertrophic cardiomyopathy patients were screened for mutations in the Ca(2+) regulatory genes, sorcin (SRI), calstabin (FKBP1B), calsequestrin (CASQ2), phospholamban (PLN), sarcolipin (SLN), calreticulin (CALR3) and calmodulin (CALM). A total of 17 exonic DNA variants were identified in the 7 Ca(2+) regulatory genes studied, of which 4 were considered of pathogenic significance. Two novel mutations in the CALR3 gene were identified (Lys82Arg, Arg73Gln) and one truncation mutation in the PLN gene (Leu39Ter). A variant was also identified in the CASQ2 gene (Asp63Glu). These four variants were all novel, resulted in changes in conserved amino acids and were not identified in a normal population. In conclusion, mutations in Ca(2+) handling genes are an infrequent but important cause of FHC. DNA variants in Ca(2+) genes may also be involved as modifying factors in phenotype development. Further evaluation of the role of defects in Ca(2+) regulation will shed light on the molecular pathogenesis of FHC.
AuthorsChristine Chiu, Molly Tebo, Jodie Ingles, Laura Yeates, Jonathan W Arthur, Joanne M Lind, Christopher Semsarian
JournalJournal of molecular and cellular cardiology (J Mol Cell Cardiol) Vol. 43 Issue 3 Pg. 337-43 (Sep 2007) ISSN: 0022-2828 [Print] England
PMID17655857 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CASQ2 protein, human
  • Calcium-Binding Proteins
  • Calreticulin
  • Calsequestrin
  • phospholamban
  • Glutamic Acid
  • Arginine
  • Glutathione
  • Calcium
  • Glycine
Topics
  • Amino Acid Sequence
  • Amino Acid Substitution
  • Arginine (metabolism)
  • Australia
  • Calcium (metabolism)
  • Calcium-Binding Proteins (genetics)
  • Calreticulin (genetics)
  • Calsequestrin (genetics)
  • Cardiomyopathy, Hypertrophic, Familial (genetics, metabolism, pathology)
  • Cohort Studies
  • Consensus Sequence
  • Conserved Sequence
  • Female
  • Genetic Testing
  • Glutamic Acid (metabolism)
  • Glutathione (metabolism)
  • Glycine (metabolism)
  • Humans
  • Male
  • Models, Genetic
  • Models, Molecular
  • Molecular Sequence Data
  • Pedigree
  • Protein Structure, Tertiary

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: